Risperidone-induced hyperprolactinemia in an elderly woman [1]

American Journal of Psychiatry

Volumn 159, Issue 12, 2002, Pages 2112-

  Bai, Ya Mei ^a   Ciu, Hsien Jane ^a   Guo, Zhao Zhan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CEFADROXIL; QUETIAPINE; RISPERIDONE; TUMOR MARKER;

AGED; AGING; AUDITORY HALLUCINATION; BIOPSY; BREAST TUMOR; CASE REPORT; CELL INFILTRATION; ECHOGRAPHY; ERYTHEMA; FEMALE; HUMAN; HYPERPROLACTINEMIA; LETTER; LEUKOCYTE; LYMPH NODE; MARRIAGE; MASTITIS; MEDICAL ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA; SKIN DISEASE; SOMATIC DELUSION;

AGED; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; MASTITIS; RISPERIDONE; SCHIZOPHRENIA;

EID: 0036895716     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.12.2112     Document Type: Letter

References (5)

1. Dickson RA, Dalby JT, Williams R, Edwards AL: Risperidone-induced prolactin elevations in premenopausal woman with schizophrenia (letter). Am J Psychiatry 1995; 152:1102-1103
2. Caracci G, Ananthamoorthy R: Prolactin levels in premenopausal women treated with risperidone compared with those of women treated with typical neuroleptics (letter). J Clin Psychopharmacol 1999; 19:194-196
3. Kearns AE, Goff DC, Hayden DL, Daniels GH: Risperidone-associated hyperprolactinemia. Endocr Pract 2000; 6:425-429
4. Kleinberg DL, Davis JM, de Coster R, Van Baelen B, Brecher M: Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 1999; 19:57-61
5. Schyve PM, Smithline F, Meltzer HY: Neuroleptic-induced prolactin level elevation and breast cancer: An emerging clinical issue. Arch Gen Psychiatry 1978; 35:1291-1301